SCHEMBL16633167

SCHEMBL16633167

Cn1cncc1C(=O)C1CCOCC1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RBP4 P02753 1/20 0.38
PREP P48147 1/20 0.37
RIPK1 Q13546 2/20 0.35
CHRM5 P08912 1/20 0.35
AKT1 P31749 1/20 0.34
PIK3CA P42336 1/20 0.34
MTOR P42345 1/20 0.34
TNKS O95271 1/20 0.34
GSK3B P49841 2/20 0.34
DYRK1A Q13627 2/20 0.34
MAPT P10636 1/20 0.34
WNT1 P04628 1/20 0.34
PRKCB P05771 1/20 0.34
CNR2 P34972 4/20 0.33
PIK3CD O00329 1/20 0.33
TBXAS1 P24557 1/20 0.32
CNR1 P21554 1/20 0.32
BRD9 Q9H8M2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL442659 0.80 HRH3 (0.48) RBP4PREPGSK3BDYRK1AWNT1
SCHEMBL16459722 0.79 RBP4 (0.44) RBP4PREPRIPK1GSK3BDYRK1A
SCHEMBL16459320 0.79 RBP4 (0.44) RBP4PREPTNKS
SCHEMBL28158302 0.76 RIPK1 (0.43) RBP4PREPRIPK1PIK3CD
SCHEMBL16632685 0.75 CNR2 (0.38) RIPK1AKT1PIK3CAMTORGSK3B
SCHEMBL16632885 0.74 KAT5 (0.37) RIPK1AKT1PIK3CAMTORGSK3B
SCHEMBL406828 0.73 GPR119 (0.53)
SCHEMBL16462782 0.70 WNT1 (0.47) RIPK1AKT1PIK3CAMTORTNKS
SCHEMBL6010185 0.69 IDO1 (0.41) RBP4PREPCHRM5TNKSMAPT
SCHEMBL15648095 0.69 LMNA (0.43) RBP4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057951-B1 METHYLENE LINKED QUINOLINYL MODULATORS OF ROR-GAMMA-T JANSSEN PHARMACEUTICA NV (BE) 2019-11-20 EP disclosed
US-9284308-B2 Methylene linked quinolinyl modulators of RORγt JANSSEN PHARMACEUTICA NV 2016-03-15 US disclosed
US-9284308-B2 Methylene linked quinolinyl modulators of RORγt JANSSEN PHARMACEUTICA NV 2016-03-15 US disclosed
US-20150105366-A1 METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt JANSSEN PHARMACEUTICA NV (BE) 2015-04-16 US disclosed
US-20150105366-A1 METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt JANSSEN PHARMACEUTICA NV (BE) 2015-04-16 US disclosed
US-20150105366-A1 METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt JANSSEN PHARMACEUTICA NV (BE) 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105366-A1 METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt RORC, RORA, RORB RBP4 289/4885PREP 2935/4885RIPK1 974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.